Le Lézard
Classified in: Health, Covid-19 virus
Subject: IMA

Acuvatm SOLARIS handheld disinfecting wand passes Validation Testing against SARS-CoV-2 (COVID-19)


BURNABY, BC, Dec. 7, 2020 /CNW/ - Acuva Technologies Inc. ("Acuva"), today announced successful validation of the Acuvatm SOLARIS handheld disinfecting wand against SARS-CoV-2 (COVID-19). The test report confirms that a >99.97% level of disinfection was achieved in 10 seconds. Validation was conducted at a biosafety level 3 (BSL-3) lab certified by the United States Centers for Disease Control (CDC) to receive, handle and use biological Select Agents. This lab conducts test and evaluation programs in the areas of infectious disease, drug development and toxicology for a wide range of clients, including multiple departments within the US Government.

The SOLARIS wand, the first of a number of new innovations being developed by Acuva in response to the global pandemic, is a portable and rechargeable UV-LED disinfection device that fits in your pocket. It delivers powerful chemical-free disinfection performance which achieves an efficacy rate of >99.9% against viruses and bacteria, including all Corona viruses. Using the Solaris device, users can safely disinfect high-touch non-porous surfaces.

"My personal ordeal with COVID-19 earlier this year gave me time to think about others facing this ruthless virus," said Manoj Singh, CEO of Acuva. "We decided to join the fight against COVID-19 by doing what we do best. We applied the same key principles used in our signature approach to UV-LED disinfection system design towards the creation of new products to help mitigate the spread of the virus." 

Featuring high-intensity germicidal UV energy, the device is thoughtfully designed for efficacy, portability, safety and ease of use. Its battery charges with a common USB-C cable so users can easily connect it to any USB port to recharge.

The SOLARIS includes a number of features to ensure safe operation, including visible blue light mapping to indicate the area being disinfected. It opens to a wide 270-degree angle to allow for faster and easier disinfection of contoured and difficult to reach surfaces, in comparison to typical sanitizing practices and cleaning solutions. A built-in sensor prevents any accidental user hand exposure to UV. It also includes a built-in timer and a power button that requires double-click activation as a child-lock function.

The Acuvatm SOLARIS is available for purchase at www.acuvastore.com. For product inquiries, please visit www.acuvatech.com.

About Acuva Technologies

Acuva is a Burnaby-based clean technology company focused on delivering advanced water, air and surface disinfection systems using leading-edge, proprietary UltraViolet Light Emitting Diode (UV-LED) technology developed in conjunction with the University of British Columbia.

Media assets, including photos of the Acuvatm SOLARIS and the Validation Report are available here: https://bit.ly/AcuvaSolarisValidation

SOURCE Acuva Technologies


These press releases may also interest you

at 09:20
Coronis Health, a trusted partner for laboratory and pathology revenue cycle management (RCM), will be a leading voice at the upcoming Executive War College (EWC) 2024 conference from April 30 to May 1 in New Orleans. As the premier forum for...

at 09:18
PRUVN Research LLC, [PRUVN], a leading research organization validating wellness products and services, is excited to announce the results of its recent preliminary study with Max International, investigating the impact of RiboCeinetm supplementation...

at 09:15
After graduating from Cornell University, Daphni Sawyer worked in healthcare for more than two years before she decided to pursue an advanced degree. In May, she will graduate with two master's degrees from Rutgers. ...

at 09:15
Thirty Madison, the specialty telemedicine company operating Keeps, Cove, and Nurx, today announced a partnership with Talkspace, a  leading online behavioral health company, to expand comprehensive mental health offerings for more than half a...

at 09:15
RevOpsis Therapeutics, a next-generation biopharmaceutical company spearheading innovation in ophthalmic therapies, announced today it has successfully closed its first seed funding round, raising $16.5 million to propel its mission to develop and...

at 09:15
Evive Brands, a leading name in the health and home services sector, announced today that all four of its flagship brands have been named to FranServe's  FRAN-TASTIC 500 list....



News published on and distributed by: